sciences, inc. bridgewater associates, lp cierra posición
TRANSCRIPT
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 1/16
Fintel ®
FondosBaker Brothers AdvisorsBaupost GroupBerkshire HathawayBridgewater AssociatesCascade InvestmentChatham Asset ManagementDuquesne Family OfficeGotham Asset ManagementMangrove PartnersMelvin CapitalPerceptive AdvisorsPoint72 Asset ManagementRenaissance TechnologiesSabby ManagementScion Asset ManagementStarboad ValueThird Point
InsidersElon MuskLisa SuEvan SpiegelJeff Bezos
CribadoresAdvanced ScreenerSample ScreensCommunity Screens
Activist TargetsDividend YieldMicrocap with RevenueNCAV ScreenNet Net Working CapitalNegative Enterprise ValuePiotroski ScoreROIC Screen
HerramientasHedge Fund Holdings TrackerCombined Portfolios ToolFinpediaLatest Activist 13D/G FilingsLatest 13F FilingsLatest Insider TradesActivist Investor ListTop Investors by AUMIndustry DataMachine Learning and AI ToolsFintel Labs
Iniciar sesión
Bridgewater Associates, LP cierra posición en GILD / GileadSciences, Inc.
DescargarTiempo de sueños
Uso de las relaciones Put / Call para comprender el sentimiento institucionalLa propiedad institucional es una medida popular, pero defectuosa, del sentimiento institucional porque incluyeparticipaciones significativas de instituciones pasivas que invierten sin la debida diligencia
Los fondos más sofisticados utilizan opciones de compra y venta para cubrir sus inversionesLa comparación de la proporción de opciones de compra y venta (la relación Put / Call) es una medida más precisa delsentimiento institucional
Ingrese el término de búsque
En línea
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 2/16
Los índices de Put / Call institucionales agregados para acciones están disponibles para los miembros Premium en las páginasde propiedad de acciones
Haga clic para comenzar (solo lleva unos segundos)
Fintel es utilizado por estas excelentes organizaciones.
Seguridad GILD / Gilead Sciences, Inc.
Institución Bridgewater Associates, LP
Gerente Ray Dalio, príncipe BobComparte 0 0Valor $ 0
Bridgewater Associates, LP cierra posición en GILD / Gilead Sciences, Inc.
13 de febrero de 2020: Bridgewater Associates, LP ha presentado un formulario 13F-HR que revela la propiedad de 0 acciones de Gilead Sciences,Inc. (NASDAQ: GILD) con tenencias totales valoradas en $ 0 USD al 31 de diciembre de 2019. Bridgewater Associates, LP había presentado un13F-HR anterior el 13 de noviembre de 2019, revelando 122,718 acciones de Gilead Sciences, Inc. por un valor de $ 7,778,000 USD. Estorepresenta un cambio en las acciones de -100.00 por ciento y un cambio en el valor de -100.00 por ciento durante el trimestre.
Otros inversores con posiciones cerradas incluyen Gamco Investors, Inc. Et Al , Tourbillon Capital Partners, LP , Clinton Group Inc , Jarislowsky,Fraser Ltd y Balyasny Asset Management Llc .
Presentaciones 13F
Las columnas de Seguridad, Clase e ID en la tabla a continuación se muestranexactamente como archivadas por el inversionista. Hacemos nuestro mejor esfuerzopara rastrear la continuidad de las inversiones a través de adquisiciones, y esto sereflejará en la tabla como cambios en los nombres y CUSIP. Además de los datosdescriptivos, el rendimiento de la inversión se muestra con el tiempo. Para calcular elrendimiento trimestral, primero calculamos la base del costo de las accionescompradas durante el trimestre, luego la usamos para calcular la ganancia bruta. Elrendimiento trimestral es el beneficio bruto / valor de la cartera inicial.
Tenga en cuenta que la base de costos se calcula y almacena en miles, por lo quepequeños cambios trimestrales en las acciones con frecuencia resultan en una basede costos de cero.
Actualice para desbloquear datos premium y exporte a Excel .
Fecha devigencia
Formar Seguridad Clase CARNÉ DEIDENTIDAD
Preciomediode la
acción
ComparteAcciones
modificadas(%)
Valor (x1000)
Valorcambiado
(%)
Asignación(%)
Basede
costos (x1000)
Beneficio(x1000)
Retorno(%)
2019-12-31 13FCIENCIASDEGILEAD
COM 375558103 0 0 -100,00 0 0 -100,00 0.00
2019-09-30 13FCIENCIASDEGILEAD
COM 375558103
2019-06-30 13FCIENCIASDEGILEAD
COM 375558103
2019-03-31 13FCIENCIASDEGILEAD
COM 375558103
31/12/2018 13FCIENCIASDEGILEAD
COM 375558103
2018-09-30 13FCIENCIASDEGILEAD
COM 375558103
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 3/16
Fecha devigencia
Formar Seguridad Clase CARNÉ DEIDENTIDAD
Preciomediode la
acción
ComparteAcciones
modificadas(%)
Valor (x1000)
Valorcambiado
(%)
Asignación(%)
Basede
costos (x1000)
Beneficio(x1000)
Retorno(%)
2018-06-30 13FCIENCIASDEGILEAD
COM 375558103
2017-03-31 13FCIENCIASDEGILEAD
COM 375558103
2016-12-31 13FCIENCIASDEGILEAD
COM 375558103
2016-09-30 13FCIENCIASDEGILEAD
COM 375558103
2016-06-30 13FCIENCIASDEGILEAD
COM 375558103
2016-03-31 13FCIENCIASDEGILEAD
COM 375558103
31/12/2015 13FCIENCIASDEGILEAD
COM 375558103
2015-09-30 13FCIENCIASDEGILEAD
COM 375558103
2015-06-30 13FCIENCIASDEGILEAD
COM 375558103
2015-03-31 13FCIENCIASDEGILEAD
COM 375558103
2014-12-31 13FCIENCIASDEGILEAD
COM 375558103
2014-09-30 13FCIENCIASDEGILEAD
COM 375558103
2014-06-30 13FCIENCIASDEGILEAD
COM 375558103
2014-03-31 13FCIENCIASDEGILEAD
COM 375558103
31/12/2013 13FCIENCIASDEGILEAD
COM 375558103
Registros relacionados con la SEC
GILD / Gilead Sciences, Inc. / VANGUARD GROUP INC Inversión pasiva
02-11 sec.gov gileadsciencesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Gilead Sciences Inc Title of Class of Securities:Common Stock CUSIP Number: 375558103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate boxto designate the rule pursuant to which this Schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) *The remainder of this coverpage shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequentamendment containing information which would alter
GILD / Gilead Sciences, Inc. / BlackRock Inc. Passive Investment
02-04 sec.gov
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 4/16
us3755581036_020419.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the SecuritiesExchange Act of 1934 (Amendment No: 9) GILEAD SCIENCES INC -------------------------------------------------------- (Name of Issuer) CommonStock -------------------------------------------------------- (Title of Class of Securities) 375558103 --------------------------------------------------------(CUSIP Number) December 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement)Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *Theremainder of this cover page shall be
GILD / Gilead Sciences, Inc. / Capital Research Global Investors - SC 13G Passive Investment
02-14 sec.gov UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities ExchangeAct of 1934 (Amendment No. )* Gilead Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 375558103 (CUSIP Number)December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thisSchedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person'sinitial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alterthe disclosures provided in a prior cover page.
GILD / Gilead Sciences, Inc. / VANGUARD GROUP INC Passive Investment
02-11 sec.gov gileadsciencesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Gilead Sciences Inc Title of Class of Securities:Common Stock CUSIP Number: 375558103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 5/16
to designate the rule pursuant to which this Schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) *The remainder of this coverpage shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequentamendment containing information which would alter
1GILD / Gilead Sciences, Inc. / Capital Research Global Investors - SC 13G Passive Investment
02-14 sec.gov - 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities ExchangeAct of 1934 (Amendment No. )* Gilead Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 375558103 (CUSIP Number)December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thisSchedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person'sinitial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alterthe disclosures provided in a prior cover page.
Related News Stories19
Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs - WSJ
11-04 wsj.com - 1 The makers of the cholesterol-lowering drug Praluent, which first went on sale for $14,600, offered to sell it for as little as $4,500, after rebates. Anew migraine drug called Aimovig, expected to cost up to $10,000 a year, went on sale for $6,900. And Zolgensma, a lifesaving gene therapy forchildren that its maker said might cost up to $5 million, was priced at $2.1 million.
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 6/16
SNY VRTX REGN AMGN GILD GCVRZ NVS SAN CI CVS SNYNF
12REFILE-Humira, Rituxan top list of U.S. costliest drug price increases -report
10-08 reuters.com NEW YORK, Oct 8 (Reuters) - AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan top the list of seven treatmentswhose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed. PFZ AMGN GILD ROG PFIZER RHHBF RHHVF BIIB RHHBY ABBV 500680 PFE RO ABBV
40The 8 Best Cash Cow Stocks to Buy for Stable Returns
08-14 investorplace.com - 2 [Editor’s note: “The 8 Best Cash Cow Stocks to Buy for Stable Returns” was previously published in March 2019. It has since been updated toinclude the most relevant information available.] BCE PM AFL GILD GOOGL GOOG MCD PAYX ATVI
383 Big Stock Charts for Monday: Xilinx, News Corp and Gilead Sciences
08-12 investorplace.com Thursday’s gain felt a little too strong to trust, and sure enough, it didn’t last. The S&P 500 fell 0.66% on Friday, leaving it squarely in the middle ofequally important support and resistance levels. NKTR XLNX GJV GE GEC AMGN NWS GILD NWSA GNE GE.WI NWSAL
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 7/16
22FOCUS-Patient groups push back against Gilead's pricey HIV prevention treatment
08-07 reuters.com LOS ANGELES (Reuters) - Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contractingthe infection, but the drugmaker faces opposition from an unusual source: patient advocates. TEVJF GILD TEVA TEVVF CI
4Gilead results beat Street estimates as demand grows for HIV drug
07-31 cnbc.com The category is picking up the slack for declining iPhone sales and includes Apple Watch, AirPods wireless earbuds and Beats headphones. GILD GLPG SMSN GPS
1Gilead Through The Eyes Of A Dividend Growth Investor - Gilead Sciences, Inc. (NASDAQ:GILD) | Seeking Alpha
07-29 seekingalpha.com - 1 Now that the sales decline comes to an end, Gilead looks like an attractive dividend growth stock to me. GLPGF GILD
Will Strong HIV Sales Drive Gilead's (GILD) Q2 Earnings?
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 8/16
07-26 zacks.com Biotech major Gilead Sciences Inc. (GILD - Free Report) is slated to report second-quarter results on Jul 30, after the market closes. REGN GILD INCY GLPG
Gilead Increases Stake in Galapagos with 10-Year Deal Worth More than $5 Billion
07-15 biospace.com Cuatro meses después de informar el éxito en dos ensayos de artritis reumatoide con su socio de desarrollo Galapagos NV, Gilead Sciences estáfortaleciendo esa asociación con una colaboración global de investigación y desarrollo de 10 años por un valor de más de $ 5 mil millones. Gileadtambién está aumentando su participación en Galápagos. GILD GLPG
2Alexion recibe la aprobación de la FDA para la expansión de etiquetas de Soliris
06-28 zacks.com - 1 Alexion Pharmaceuticals, Inc. (ALXN - Informe gratuito) anunció que la FDA aprobó una expansión de la etiqueta del medicamento con plomo,Soliris (eculizumab). ALXN GILD AKTX CLTX ACHN
CUSIP: 375558103 ISIN: US3755581036Último precio y tamaño del lote
74.93 / 100 a
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 9/16
partir del 20/03/2020, 1:44:12 PM ET
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 10/16
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 11/16
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 12/16
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 13/16
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 14/16
Sitios que disfrutamosQuantSoft Capital Partners: aplicación delaprendizaje automático en los mercados de capitalesFinpedia - Ciencias de GalaadWolfStreetRealInvestmentAdvice
crossout.net VISITAR
Crea, Conduce, Destrózalo Todo
Anuncio
Institutional and Hedge FuInstitutional and Hedge Fu……
Insider Trading Tutorial - bInsider Trading Tutorial - b……
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 15/16
crossout.net VISITAR
Crea, Conduce, Destrózalo Todo
Anuncio
METTLER TOLEDO ABIERTO
Medición de conductividad - Guía de teoríagratuita
Anuncio
20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io
https://fintel.io/so/us/gild/bridgewater-associates-lp 16/16
Herramientas para inversoresHerramienta de acciones combinadas
Cree su propio portafolio de alta convicción combinando las posiciones de los fondos líderes e identificando las acciones más comúnmentemantenidas
Probar ahora
Advanced Stock Screener
Analice el mercado de ideas de inversión utilizando expresiones complejas.
Probar ahora
Hedge Fund Holdings TrackerEncuentre ideas de inversión de alta convicción examinando las tenencias combinadas de instituciones líderes
Probar ahora
Fintel® provides advanced research tools for data-driven investorsFintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX).
© 2015-2020 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.See our Privacy Policy.
Este sitio web se proporciona "tal cual" sin ninguna representación o garantía, expresa o implícita. Fintel no hace representaciones ni garantías enrelación con este sitio web o la información y los materiales proporcionados en este sitio web. Nada en este sitio web constituye, o pretendeconstituir, asesoramiento de ningún tipo. Si necesita asesoramiento en relación con cualquier asunto financiero, debe consultar a un profesionalapropiado. Datos de precios en tiempo real proporcionados por IEX . Datos del tablero de mensajes proporcionados por SiliconInvestor .
En construcción: el sitio web está siendo escaneado por cookies por primera vez.